Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.
about
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs EraImmunity to Infections after Haploidentical Hematopoietic Stem Cell TransplantationPlanes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.Halfway there: the past, present and future of haploidentical transplantation.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Mechanistic approaches for the prevention and treatment of chronic GVHD.Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation.Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.Cytokine mediators of chronic graft-versus-host disease.Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation.
P2860
Q28072397-635F5E1F-2645-4506-B1E9-9B67DC3AFE17Q28079606-2CFBC25E-5ADB-4689-AFC9-90837C7D9BB6Q38823260-4C05426A-F932-4D82-A808-D6670D1D2900Q38838264-88FDDB79-392A-4E39-B703-98158298A241Q39002164-636143A8-8796-4DD7-B558-51DBC042B5FAQ39002166-071789B7-8456-4D9A-B4C1-5EF362352D3AQ39232824-CDEDCA71-8104-4FA9-9861-49F9DBC4C8ECQ41092916-35CEF361-4D6D-4F72-8205-B97AC7C8A96AQ47572499-A57208CF-441A-41F8-BC61-C8860930820EQ47847626-2D464A89-C0DC-42D4-AF16-4D3AE42B40A1Q50915048-FDC3C8B6-B1A3-46F6-9392-A16B6B1C938AQ51783552-C1C8BFFB-70D6-4B68-AAEF-D6AC24A24583Q53082542-90634D3C-FF84-4332-9A07-7DBF89117DA9Q55060181-BDE11EC9-709B-4999-B0DE-B5608803D77F
P2860
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@ast
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@en
type
label
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@ast
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@en
prefLabel
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@ast
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@en
P2093
P2860
P1476
Haploidentical bone marrow and ...... nsplantation cyclophosphamide.
@en
P2093
Ephraim J Fuchs
Leo Luznik
Paul V O'Donnell
Tara M Robinson
P2860
P356
10.1053/J.SEMINHEMATOL.2016.01.005
P577
2016-01-15T00:00:00Z